- Home
- BOWN vs NRXP Comparison
BOWN vs NRXP Comparison
Compare BOWN & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOWN
- NRXP
- Stock Information
- Founded
- BOWN 2023
- NRXP 2015
- Country
- BOWN United States
- NRXP United States
- Employees
- BOWN N/A
- NRXP N/A
- Industry
- BOWN
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- BOWN
- NRXP Health Care
- Exchange
- BOWN Nasdaq
- NRXP Nasdaq
- Market Cap
- BOWN 28.5M
- NRXP 32.6M
- IPO Year
- BOWN 2023
- NRXP N/A
- Fundamental
- Price
- BOWN $9.20
- NRXP $3.05
- Analyst Decision
- BOWN
- NRXP Strong Buy
- Analyst Count
- BOWN 0
- NRXP 4
- Target Price
- BOWN N/A
- NRXP $28.50
- AVG Volume (30 Days)
- BOWN 2.5K
- NRXP 193.0K
- Earning Date
- BOWN 01-01-0001
- NRXP 08-13-2025
- Dividend Yield
- BOWN N/A
- NRXP N/A
- EPS Growth
- BOWN N/A
- NRXP N/A
- EPS
- BOWN 0.02
- NRXP N/A
- Revenue
- BOWN N/A
- NRXP N/A
- Revenue This Year
- BOWN N/A
- NRXP N/A
- Revenue Next Year
- BOWN N/A
- NRXP N/A
- P/E Ratio
- BOWN $201.47
- NRXP N/A
- Revenue Growth
- BOWN N/A
- NRXP N/A
- 52 Week Low
- BOWN $2.71
- NRXP $1.10
- 52 Week High
- BOWN $19.77
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- BOWN 43.24
- NRXP 44.37
- Support Level
- BOWN $9.14
- NRXP $3.03
- Resistance Level
- BOWN $10.20
- NRXP $3.53
- Average True Range (ATR)
- BOWN 0.39
- NRXP 0.17
- MACD
- BOWN -0.03
- NRXP -0.06
- Stochastic Oscillator
- BOWN 39.35
- NRXP 4.95
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.